Mesoblast Share Price Today: Live Updates & Key Insights
Mesoblast share price today is $14.36, up -2.84%. The stock opened at $14.79 against the previous close of $14.78, with an intraday high of $14.89 and low of $14.24.
Mesoblast Share Price Chart
Mesoblast Share Price Performance
Mesoblast Institutional Holdings
Mesoblast Market Status
Mesoblast Fundamentals
Market Cap 1936.97 M
PB Ratio 3.2197
PE Ratio 0.0
Enterprise Value 1884.95 M
Total Assets 784.68 M
Volume 259346
Mesoblast Company Financials
About Mesoblast & investment objective
Company Information Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It offers Remestemcel-L, which is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease and biologic refractory inflammatory bowel disease, as well as ulcerative colitis and Crohn's disease; and Remestemcel-L, which is in Phase III clinical trials to treat chronic heart failure and chronic low back pain due to degenerative disc disease. The company is also developing MPC-300-IV to treat biologic refractory rheumatoid arthritis diabetic nephropathy. It has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for the treatment or prevention of chronic heart failure; MPC-25-IC for the treatment or prevention of acute myocardial infarction; and Ryoncil for the treatment of pediatric SR-aGVHD; JCR Pharmaceuticals Co. Ltd. to treat wound healing in patients with epidermolysis bullosa and for the treatment of neonatal hypoxic ischemic encephalopathy; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. The company was incorporated in 2004 and is headquartered in Melbourne, Australia.
Organisation Biotechnology
Employees 81
Industry Biotechnology
CEO Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Mesoblast FAQs
What is the share price of Mesoblast today?
The current share price of Mesoblast is $14.36.
Can I buy Mesoblast shares in India?
Yes, Indian investors can buy Mesoblast shares by opening an international trading and demat account with Motilal Oswal.
How to buy Mesoblast shares in India?
You can easily invest in Mesoblast shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Mesoblast shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Mesoblast.
Can I buy fractional shares of Mesoblast?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Mesoblast?
Mesoblast has a market cap of $1936.97 M.
In which sector does Mesoblast belong?
Mesoblast operates in the Biotechnology sector.
What documents are required to invest in Mesoblast stocks?
To invest, you typically need:
What is the PE and PB ratio of Mesoblast?
The PE ratio of Mesoblast is N/A and the PB ratio is 3.22.